|
Match
|
Document |
Document Title |
|
|
US20130202696 |
Agent for use in the case of fructose intolerance
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose... |
|
|
US20110243956 |
METHODS OF DIAGNOSING AND TREATING COMPLICATIONS OF PREGNANCY
Disclosed herein are methods for diagnosing a pregnancy related hypertensive disorder or a predisposition to a pregnancy related hypertensive disorder by measuring the level or biological activity... |
|
|
US20110117171 |
IMPLANTABLE BONE GRAFT MATERIALS
Compositions and methods are provided for promoting bone growth. An implantable bone graft material is provided comprising a resorbable ceramic and a resorbable polymer, wherein the polymer... |
|
|
US20110117165 |
IMPLANTABLE BONE GRAFT MATERIALS
Compositions and methods are provided for promoting bone growth. An implantable bone graft material is provided comprising a resorbable ceramic and a resorbable polymer, wherein the polymer... |
|
|
US20090104283 |
METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS
The present invention relates to the use of polyunsaturated fatty acids andone or more components which have a beneficial effect on total methioninemetabolism selected from the group consisting of... |
|
|
US20160000870 |
METHODS AND COMPOSITIONS FOR DELIVERING INTERLEUKIN-1 RECEPTOR ANTAGONIST
Methods, systems, and compositions related to generating and using a solution rich in interleukin-1 receptor antagonist are provided. Methods include contacting a liquid comprising white blood... |
|
|
US20150174093 |
COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND MAGNESIUM
The invention relates to the combination of a sulforaphane precursor, an enzyme capable of converting the sulforaphane precursor to sulforaphane, an enzyme potentiator, and magnesium or a salt or... |
|
|
US20140205684 |
MACROPHAGE INHIBITORY CYTOKINE-1 (MIC-1) AS A PROGNOSTIC MARKER IN CHRONIC KIDNEY DISEASE
The present invention relates to methods of prognosing the survival of a diseased subject, particularly a subject with chronic kidney disease (CKD), as well as selecting an end-stage renal disease... |
|
|
US20140044685 |
NUTRITIONAL COMPOSITIONS HAVING ALPHA-HICA AND CITRULLINE
Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional... |
|
|
US20120177744 |
METHOD OF USING BETA-HYDROXY-BETA-METHYLBUTYRATE FOR THE TREATMENT OF CANCER
Disclosed are methods of treating an individual having a condition characterized by an imbalance in type 1 and type 2 cytokine production, wherein the method comprises administering to the... |
|
|
US20120027828 |
Dental anti-hypersensitivity composition and method
The present invention relates to compositions and methods for calcifying dental tissue, e.g., preventing or treating dental hypersensitivity. An oral composition of arginine bicarbonate and... |
|
|
US20110305771 |
Krill Extracts for Treatment of Cardiovascular Diseases
The present invention relates to a method of treatment and/or prevention of cardiovascular disease, rheumatoid arthritis, skin cancer, premenstrual syndrome, diabetes and transdermal transport... |
|
|
US20090258069 |
Delivery of LFA-1 antagonists to the gastrointestinal system
The present invention provides compositions and methods for treating disorders and diseases by delivery of LFA-1 antagonists to the gastrointestinal system. Methods include delivery of LFA-1... |
|
|
US20140099387 |
COMPOSITIONS AND METHODS FOR TREATMENT
The present invention provides compounds and methods for the treatment of LFA-1 mediated diseases. In particular, LFA-1 antagonists are described herein and these antagonists are used in the... |
|
|
US20110244039 |
ABSORBABLE SOLID COMPOSITIONS FOR TOPICAL TREATMENT OF ORAL MUCOSAL DISORDERS
The invention provides a solid, self-bioadhesive composition for topical application that adheres to the oral mucosal tissue comprising a therapeutically effective amount of at least one herbal or... |
|
|
US20090311235 |
Use of Polymeric Materials with Other Substances for Improved Performance
Methods of enabling or improving the ability of a hydrogel to swell in the stomach of an animal and/or increasing the amount of time said hydrogel remains swollen in the stomach are described... |
|
|
US20080187604 |
LIQUID CHALCOGENIDE COMPOSITIONS AND METHODS OF MANUFACTURING AND USING THE SAME
The present invention provides novel stable, liquid compositions comprising chalcogenides or salts thereof. These compositions may be used for a variety of purposes, including the treatment and... |
|
|
US20070092579 |
Medical Products and Parenteral Formulations
A medical product and parenteral formulation are provided. The parenteral formulation is preferably for fluid restricted patients such as pediatric patients and can include amino acids, lipids,... |
|
|
US20050037070 |
Pharmaceutical formulatins useful for inhibiting acid secretion and methods for making and using them
In one general aspect of the present invention, pharmaceutical formulations comprising both a proton pump inhibitor microencapsulated with a material that enhances the shelf-life of the... |
|
|
US20160166598 |
A METHOD FOR TREATING INFECTION, SEPSIS AND INJURY
The invention relates to a composition or method for treating at least one of infection, sepsis and injury or inducing a hypotensive state or a low pain or analgesic state in a subject susceptible... |
|
|
US20160158280 |
A METHOD FOR ORGAN ARREST, PROTECTION AND PRESERVATION AND REDUCING TISSUE INJURY
The invention relates to compositions and methods for Inducing organ arrest, maintaining arrest and reanimating in a subject that has suffered a life threatening disease or injury; preparing,... |
|
|
US20090191282 |
CONTROLLED RELEASE COMPOSITION CONTAINING A STRONTIUM SALT
A controlled release pharmaceutical composition comprising a strontium salt. The invention also relates to the use of a strontium salt for treating a male suffering from diseases and conditions... |
|
|
US20080069855 |
METHOD OF INHIBITING THE FORMATION OF ADHESIONS AND SCAR TISSUE AND REDUCING BLOOD LOSS
The present invention provides a method for inhibiting the formation of scar tissue and/or exogenous bone at a wound site in a body of a patient. The method includes administering an amount of a... |
|
|
US20160030474 |
Brain, Spinal and Nerve Injury Treatment
A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use... |
|
|
US20150064285 |
SLOW RELEASE MAGNESIUM COMPOSITION AND USES THEREOF
The present invention provides compositions that contain magnesium and threonate, or a threonate precursor molecule, formulated for extended or modified release to provide physiological... |
|
|
US20110171188 |
NON-THERMAL PLASMA FOR WOUND TREATMENT AND ASSOCIATED APPARATUS AND METHOD
The invention relates to a non-thermal plasma for treatment of a surface, particularly for the treatment of a wound (1), wherein the plasma comprises a partially ionized carrier gas and at least... |
|
|
US20050186288 |
Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
Disclosed is a topical method for providing highly effective analgesic, anti-inflammatory, antimicrobial and tissue-regenerating activities for the hitherto most effective prophylaxis and... |
|
|
US20140147520 |
Water-based Personal Moisturizers and Lubricants, in Particular Vaginal Lubricants, and Uses Thereof
There is a need for water-based sperm- and egg-friendly vaginal lubricant. We describe novel water-based nature-friendly personal moisturizers and lubricants that relieve vaginal dryness. In... |
|
|
US20110256097 |
Treatment of Conditions that Increase in Severity and/or Occurrence During One or More Phases of the Menstrual Cycle
Methods are provided for treating a subject for a condition. In accordance with the subject methods, at least a portion of a subject's autonomic nervous system is modulated during at least one... |
|
|
US20100209541 |
BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING METABOLIC DISORDERS
Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in... |
|
|
US20080317807 |
STRONTIUM FORTIFIED CALCIUM NANO-AND MICROPARTICLE COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
Compositions containing strontium fortified calcium nanoparticles and/or microparticles, and methods of making and using thereof are described herein. The strontium fortified calcium compounds... |
|
|
US20080267940 |
Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue
The present invention is drawn to concentrated fibrinogen compositions and associate methods and use thereof. The concentrated fibrinogen compositions can be produced by adding a sufficient amount... |
|
|
US20050031700 |
Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
Pharmaceutical formulations in the form of a powder for suspension comprising at least one proton pump inhibitor in micronized form; at least one antacid; and at lest one suspending agents are... |
|
|
US20150273022 |
STABILIZED ULTRA-RAPID-ACTING INSULIN FORMULATIONS
Compositions and methods for enhancing the stability of rapid acting injectable insulin formulations have been developed for subcutaneous injection. The formulations contain insulin in combination... |
|
|
US20080193564 |
METHOD FOR PREVENTING OR REDUCING SECONDARY FRACTURES AFTER HIP FRACTURE
Use of a bisphosphonate in the preparation of a medicament for the treatment of osteoporosis post hip fracture to prevent or reduce subsequent osteoporotic skeletal fractures in a patient in need... |
|
|
US20070003596 |
DRUG DEPOT FOR PARENTERAL, IN PARTICULAR INTRAVASCULAR, DRUG RELEASE
A drug depot suitable for the parenteral, in particular intravascular, release of at least one drug which may be present as a base or corresponding protonised salt, wherein the base has a pKb... |
|
|
US20060142212 |
Nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
A nutrient pharmaceutical formulation composition useful for treating cancer comprising ascorbic acid, L-lysine, L-proline and at least one polyphenol compound selected from the group consisting... |
|
|
US20170080121 |
BIORESORBABLE METAL ALLOY AND IMPLANTS MADE OF SAME
Disclosed herein is a non-toxic, bioresorbable, magnesium based alloy for use in production of implants. Specifically exemplified herein are alloy embodiments useful for orthopedic implants. Also... |
|
|
US20150072019 |
FGFR INHIBITOR FOR USE IN THE TREATMENT OF HYPOPHOSPHATEMIC DISORDERS
The present invention relates generally to 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piper
azin-1-yl)-phenylamino]-pyrimid-4-yl}-1-methyl-urea or a pharmaceutically acceptable salt or... |
|
|
US20120258156 |
SHAPED COMPOSITIONS FOR UNIFORM DELIVERY OF A FUNCTIONAL AGENT
Shaped compositions are provided for use in delivering a substantially uniform concentration of a functional agent (e.g., an antimicrobial sanitizing agent) to a flowing stream of water. The... |
|
|
US20080193531 |
COMPOSITIONS FOR IMPROVING GASTROINTESTINAL NUTRIENT AND DRUG ABSORPTION
The present invention provides pharmaceutical compositions and methods for improving the absorption of nutrients and/or drugs in the gastrointestinal tract of a subject. Typically, the... |
|
|
US20090186013 |
INORGANIC MATERIALS FOR HEMOSTATIC MODULATION AND THERAPEUTIC WOUND HEALING
The invention provides compositions, methods and devices relating to a silaceous oxide that generates a reduced heat of hydration upon contact with blood. By reducing the heat of hydration, the... |
|
|
US20090142314 |
MATERNAL SUPPLEMENT
The use of docosahexaenoic acid in the manufacture of a composition for administration to a pregnant woman for reducing the risk of development of overweight or obesity of the baby in infancy... |
|
|
US20070286909 |
Amino acid compositions
Compositions are described herein that are nutritional supplements that contain free amino acids. These supplements contain a homogenous mixture of free amino acids, wherein the free-form amino... |
|
|
US20060240125 |
Composition for affecting weight loss
A composition for reducing the weight of a human. The composition is provided in the form of a capsule comprising an effective amount of capsaicin and/or analogs thereof, L-tyrosine, supplemental... |
|
|
US20060024384 |
Compositions and methods for nutrition supplementation
The present invention relates to compositions, that may be swallowable, chewable or dissolvable, comprising various vitamins and minerals, and in a specific embodiment, comprise vitamin B6,... |
|
|
US20050180957 |
Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells
The present invention relates to compositions and methods of treating a disease, such as diabetes, by implanting encapsulated biological material with a growth factor and conjugate into a patient... |
|
|
US20130295150 |
ELECTRICITY-GENERATING PARTICULATES AND THE USE THEREOF
The invention features a galvanic particulate including a first conductive material and a second conductive material, wherein both the first conductive material and the second conductive material... |
|
|
US20110052678 |
METHOD FOR TREATING AGE RELATED MACULAR DEGENERATION
A method for treating age related macular degeneration uses insulin preparation applied topically in a therapeutically effective amount to an affected conjunctival sac of the eye. The topically... |
|
|
US20140369984 |
BIOMATERIAL FOR ARTICULAR CARTILAGE MAINTENANCE AND TREATMENT OF ARTHRITIS
The present disclosure provides biomaterials and methods for preventing and minimizing progression of cartilage and/or connective tissue damage. Also provided herein are biomaterials and methods... |